Rhumbline Advisers Rani Therapeutics Holdings, Inc. Put Options Transaction History
Rhumbline Advisers
- $109 Billion
- Q4 2024
Put Options
0 transactions
Quarter | Operation | Price Per put | puts change | puts Held | SEC Form |
---|---|---|---|---|---|
Quarter | Operation | Price Per put | puts change | puts Held | SEC Form |
Others Institutions Holding RANI
# of Institutions
47Shares Held
3.68MCall Options Held
44KPut Options Held
193K-
Vanguard Group Inc Valley Forge, PA710KShares$1.06 Million0.0% of portfolio
-
Nan Fung Group Holdings LTD Central, K3494KShares$740,3760.67% of portfolio
-
Alphabet Inc. Mountain View, CA448KShares$672,7380.04% of portfolio
-
United Services Automobile Association San Antonio, TX303KShares$454,1140.01% of portfolio
-
Two Sigma Investments, LP New York, NY291KShares$437,0710.0% of portfolio
About Rani Therapeutics Holdings, Inc.
- Ticker RANI
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 24,492,000
- Market Cap $36.7M
- Description
- Rani Therapeutics Holdings, Inc. operates as a clinical stage biotherapeutics company that develops orally administered biologics. The company develops the RaniPill capsule, a platform that is intended to replace subcutaneous or IV injection of biologics with oral dosing. Its product pipeline includes RT-101, an octreotide, which has completed P...